ARMP · Forms 3, 4, 5
Insider trades at Armata Pharmaceuticals, Inc.
No open-market insider buys or sells at Armata Pharmaceuticals, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Armata Pharmaceuticals, Inc. (ARMP) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Armata Pharmaceuticals, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Deborah Birx | Chief Executive Officer | Tax withholding | 14,041 | $4.26 | $60K | Form 4 | |
| Daniel B. Gilmer | Director | Options or other derivatives | Form 4 | ||||
| Daniel B. Gilmer | Director | Became an insider (Form 3) | Form 3 | ||||
| Pierre Kyme | Chief Business Officer | Tax withholding | 1,030 | $10.54 | $11K | Form 4 | |
| Deborah Birx | Chief Executive Officer | Tax withholding | 4,919 | $10.54 | $52K | Form 4 | |
| Robin Kramer | Director | Options or other derivatives | Form 4 | ||||
| Pierre Kyme | Chief Business Officer | Options or other derivatives | Form 4 | ||||
| David Duane House | SVP, Finance, and PFO | Options or other derivatives | Form 4 | ||||
| Joseph M Patti | Director | Options or other derivatives | Form 4 | ||||
| Todd C. Peterson | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.